BioCentury
ARTICLE | Company News

Amgen, Carmot deal

January 20, 2014 8:00 AM UTC

Carmot and Amgen partnered to use Carmot's Chemotype Evolution fragment-based lead discovery technology to discover novel drug leads for two undisclosed targets selected by Amgen. Carmot and Amgen wil...